Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05846659
Title Study of PULSAR-ICI +/- IMSA101 in Patients With Oligoprogressive Solid Tumor Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ImmuneSensor Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Orange County Lennar Foundation Cancer Center Irvine California 92618 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
UCLA Los Angeles California 90095 United States Details
Northwestern Memorial Hospital Chicago Illinois 60611 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Brigham and Women's Hospital/Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016 United States Details
Louis Stokes Cleveland VA Medical Center Cleveland Ohio 44106 United States Details
MetroHealth Medical Center Cleveland Ohio 44109 United States Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
Baylor College of Medicine Medical Center Houston Texas 77030 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field